Sonoma Pharmaceuticals (SNOA) Current Taxes (2016 - 2017)
Sonoma Pharmaceuticals' (SNOA) quarterly Current Taxes came in at $13000.0 in Q1 2017, down 94.32% quarter-over-quarter from $229000.0 in Q4 2016.
Sonoma Pharmaceuticals (SNOA) Current Taxes (2016 - 2017) Analysis & Trends
Sonoma Pharmaceuticals' Current Taxes history runs 2 years deep, the most recent figure standing at $13000.0 for Q1 2017.
- On a quarterly basis, Current Taxes changed N/A year-over-year to $13000.0 in Q1 2017; TTM through Mar 2017 was $13000.0, a N/A change from a year earlier, with the FY2017 full-year figure at $13000.0, changed N/A from the prior year.
- Current Taxes slipped to $13000.0 in Q1 2017 per SNOA's latest filing, from $229000.0 in the prior quarter.
- Across five years, Current Taxes topped out at $229000.0 in Q4 2016 and bottomed at $13000.0 in Q1 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 355.15 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 211.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 624.14 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 640.78 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Sonoma Pharmaceuticals | 179.80 | -2.40 Mn | 2.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | 13,000.00 |
| Dec 31, 2016 | 229,000.00 |